💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

Panacea Biotec Ltd (PNCA)

NSE
Currency in INR
Disclaimer
245.92
+7.17(+3.00%)
Closed
PNCA Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
238.80255.60
52 wk Range
112.35262.60
Bid/Ask
245.87 / 245.92
Prev. Close
238.75
Open
238.9
Day's Range
238.8-255.6
52 wk Range
112.35-262.6
Volume
1,159,949
Average Volume (3m)
604,881
1-Year Change
83.8%
Fair Value
Unlock
Fair Value Upside
Unlock
PNCA Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Panacea Biotec Ltd Company Profile

Panacea Biotec Limited, a biotechnology company, engages in the research and development, manufacture, and marketing of pharmaceutical formulations and vaccines in India. It operates through Vaccines and Formulations segments. The company’s product portfolio includes prescription products in various therapeutic areas, such as pain management, diabetes and cardiovascular management, oncology, renal disease management, osteoporosis management, and gastro-intestinal care; and pneumococcal vaccine, dengue tetravalent vaccine, typhoid conjugate vaccine, and universal flu vaccine. It also exports its products to approximately 36 countries, including the United States, Germany, Russian Federation, Turkey, Bosnia, Tanzania, Kenya, Serbia, Vietnam, Philippines, Sri Lanka, etc. The company has a collaboration agreement with the Russian Direct Investment Fund for producing Covid-19 vaccine, Sputnik-V; and the Coalition for Epidemic Preparedness Innovations and Translational Health Science and Technology Institute to develop vaccine candidates that could protect against SARS-Cov-2 variants and other Beta coronaviruses. The company was incorporated in 1984 and is based in New Delhi, India.

Employees
1815
Market
India

Compare PNCA to Peers and Sector

Metrics to compare
PNCA
Peers
Sector
Relationship
P/E Ratio
−54.0x33.2x−0.6x
PEG Ratio
0.300.600.00
Price/Book
1.8x5.9x2.6x
Price / LTM Sales
2.8x5.2x3.1x
Upside (Analyst Target)
-−2.5%58.1%
Fair Value Upside
Unlock−8.3%9.2%Unlock

FAQ

What Is the Panacea Biotec (PNCA) Stock Price Today?

The Panacea Biotec stock price today is 245.92.

What Stock Exchange Does Panacea Biotec Trade On?

Panacea Biotec is listed and trades on the NSE stock exchange.

What Is the Stock Symbol for Panacea Biotec?

The stock symbol for Panacea Biotec is "PNCA."

What Is the Panacea Biotec Market Cap?

As of today, Panacea Biotec market cap is 15.06B.

What is Panacea Biotec Earnings Per Share?

The Panacea Biotec EPS is -4.53.

What Is the Next Panacea Biotec Earnings Date?

Panacea Biotec will release its next earnings report on 12 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.